Showing results (11-20 of 51) with videos related to
Sort By:
Pageof 6
Anticancer Research|May 17, 2019
Death Receptor 6 (DR6) Is Overexpressed in AstrocytomasSarah Stegmann, Jan-Michael Werner, Saskia Kuhl, et al.Clinical Nuclear Medicine|April 7, 2021
Uncovering an Optic Nerve Sheath Meningioma Using 68Ga-DOTATATE PET/CTSabine Ulrike Vay, Jan-Michael Werner, Christoph Kabbasch, et al.Brain Pathology (Zurich, Switzerland)|February 25, 2022
Use of advanced neuroimaging and artificial intelligence in meningiomasNorbert Galldiks, Frank Angenstein, Jan-Michael Werner, et al.International Journal of Molecular Sciences|April 6, 2018
Dabrafenib Treatment in a Patient with an Epithelioid Glioblastoma and BRAF V600E MutationGarry Ceccon, Jan-Michael Werner, Veronika Dunkl, et al.Anticancer Research|September 6, 2017
Discordance and Conversion Rates of Progesterone-, Estrogen-, and HER2/neu-Receptor Status in Primary Breast Cancer and Brain Metastasis Mainly Triggered by Hormone TherapyMarco Timmer, Jan-Michael Werner, Gabriele Röhn, et al.Journal of Neuro-Oncology|December 28, 2022
Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomasMichael M Wollring, Jan-Michael Werner, Garry Ceccon, et al.Clinical Nuclear Medicine|February 9, 2023
Differentiation of a Falcine Meningioma From Cerebral Venous Sinus Thrombosis Using DOTATATE PETIsabelle Stetter, Jan-Michael Werner, Michael Schroeter, et al.Frontiers in Oncology|March 5, 2019
Successful Treatment of Myasthenia Gravis Following PD-1/CTLA-4 Combination Checkpoint Blockade in a Patient With Metastatic MelanomaJan-Michael Werner, Viola Schweinsberg, Michael Schroeter, et al.Neuro-Oncology Advances|September 29, 2025
Advancements in noninvasive visualization of the immune environment in glioblastoma: A systematic reviewPhilipp Lohmann, Laura Schäfer, Sandra Krause, et al.Neuro-Oncology Advances|February 1, 2021
Feature-based PET/MRI radiomics in patients with brain tumorsPhilipp Lohmann, Anna-Katharina Meißner, Martin Kocher, et al.Pageof 6